Key takeaways Enclomiphene is the trans-isomer of clomiphene citrate, a selective estrogen receptor modulator (SERM) that works upstream on the brain rather than supplying testosterone directly. It is not FDA-approved for any use; in the US it is available only as a compounded, prescription-only drug used off-label in men, and the FDA has not evaluated […]
Key takeaways In a systematic review of hypogonadal men, effects of testosterone treatment on sexual interest typically began around 3 weeks and plateaued near 6 weeks, while fuller effects on spontaneous erections could take up to 6 months (Saad et al., European Journal of Endocrinology, 2011). Different outcomes move on different clocks: mood changes often […]
Key takeaways Low desire is the most common female sexual complaint, but it is only diagnosed as hypoactive sexual desire disorder (HSDD) when it causes marked personal distress — reported in the PRESIDE survey in roughly 8.9% of women at ages 18–44, 12.3% at 45–64, and 7.4% at 65 and older. There is no FDA-approved […]
Key takeaways Sermorelin is a growth hormone secretagogue, not HGH: it prompts your own pituitary to release growth hormone in natural pulses rather than supplying the hormone from outside. Robust, modern human trials of sermorelin for sleep, recovery, or body composition in healthy aging adults are lacking; its strongest evidence is decades-old data in growth-hormone-deficient […]
Key takeaways On the historical FDA label for sermorelin acetate (Geref), the most common treatment-related side effect was a local injection-site reaction (pain, swelling, or redness), reported in about 1 patient in 6. All sermorelin available in the United States in 2026 is compounded under sections 503A/503B. Compounded sermorelin is not FDA-approved and has not […]
Key takeaways Sermorelin is given by subcutaneous injection. In its FDA-approved pediatric history and pivotal trial it was dosed once daily, and the studied timing was at bedtime, but that figure was a pediatric study dose and is reference-only, not a recommendation for adult wellness use. The bedtime-dosing rationale is often described as aligning with […]
Key takeaways The honest answer on sermorelin before and after is that high-quality evidence is limited, small, and mostly dated, so no reliable percentage outcomes exist and any reported changes are anecdotal and not guaranteed. Sermorelin is a synthetic GHRH analog that prompts your own pituitary to release growth hormone; it is not the same […]
Key takeaways Persistent hot flashes, night sweats, sleep disruption, vaginal dryness, mood changes, or low libido that interfere with daily life are commonly cited signs that may prompt a conversation about hormone replacement therapy with a licensed provider. For women older than about 45 with typical symptoms, menopause is generally a clinical diagnosis and routine […]
Key takeaways There is no single “correct” TRT dosage. FDA labels list reference ranges by form, but the right approach is individualized by a licensed provider to your lab results and symptoms, and you should never self-dose. FDA-approved testosterone comes in several forms, including intramuscular cypionate injection, subcutaneous enanthate (Xyosted), transdermal gels (AndroGel), and implantable […]
Key takeaways Reported enclomiphene side effects in men may include headache, dizziness, nausea, hot flashes, mood changes and elevated estradiol, though the available datasets are small and long-term safety has not been established. Because enclomiphene is a selective estrogen receptor modulator (SERM) related to clomiphene, regulators flag class-level risks such as visual disturbances, some of […]
